The present invention provides chimeric receptors. The chimeric receptors comprise at least one region homologous to a region of a metabotropic glutamate receptor and at least one region homologous to a region of a calcium receptor. The invention also includes methods of preparing such chimeric receptors, and methods of using such receptors to identify and characterize compounds which modulate the activity of metabotropic glutamate receptors or calcium receptors.
The invention also relates to compounds and methods for modulating metabotropic glutamate receptor activity and binding to metabotropic glutamate receptors. Modulation of metabotropic glutamate receptor activity can be used for different purposes such as treating neurological disorders and diseases, inducing an analgesic effect, cognition enhancement, and inducing a muscle-relaxant effect.
本发明提供嵌合受体。嵌合受体包括至少一个与代谢谷
氨酸受体区域同源的区域和至少一个与
钙受体区域同源的区域。本发明还包括制备这种嵌合受体的方法,以及利用这种受体鉴定和表征调节代谢谷
氨酸受体或
钙受体活性的化合物的方法。
本发明还涉及调节代谢型谷
氨酸受体活性和与代谢型谷
氨酸受体结合的化合物和方法。调节代谢型谷
氨酸受体活性可用于不同目的,如治疗神经紊乱和疾病、诱导镇痛效果、增强认知能力和诱导肌肉放松效果。